We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SARTORIUS AG

Sartorius AG is a developer of bioprocess solutions and laboratory products and services that enable pharmaceutical r... read more Featured Products: More products

Download Mobile App




New Bioreactor System Streamlines Strain Screening and Culture

By LabMedica International staff writers
Posted on 23 Nov 2015
Biotechnology laboratories working with bacterial cultures will benefit from a new automated micro bioreactor system that was designed to enhance microbial strain screening processes.

The Sartorius Stedim Biotech (Aubagne, France) new ambr 15 fermentation system comprises 24 single-use stirred micro-bioreactors (each with an 8 to 12 milliliter working volume) integrated with a user-friendly, automated workstation. More...


The system, which is based on Sartorius' gold-standard ambr 15 micro-bioreactor technology, offers parallel processing and walk-away control of 24 micro-bioreactors. These features provide the researcher with efficient, consistent results from an enhanced early stage screening platform.

The ambr 15 system was designed to deliver high oxygen transfer rates, rapid pH and feed additions, and is ideally suited for assessing the effects of different strains of microbial cultures. The instrument measures pH and dissolved oxygen every 12 seconds, and computer controlled pumps feed liquid lines for base and nutrient addition to each micro bioreactor.

Each single-use micro bioreactor vessel contains an impeller suitable for fermentation and provides enhanced capability compared to shaking culture systems. Since the ambr 15 vessels are single-use and are supplied sterile, cleaning and sterilization are eliminated, which decreases turnaround times between runs.

Dr. Barney Zoro, ambr product manager at Sartorius Stedim Biotech said, “Scientists have been trying to model microbial fermentation and screen microbial strains using shake plates and flasks but these devices are poor early stage models as they are not able to achieve representative cell densities, and do not allow monitoring and control of pH or dissolved oxygen. With these issues in mind, we developed ambr 15 fermentation and have data showing system consistency, repeatability, and predictive selection of strains. This demonstrates that the system is an excellent tool for enhanced screening applications, and we are confident that fermentation scientists will significantly reduce their time and resource demands when performing enhanced microbial strain selection studies using an ambr 15 fermentation system.”

Related Links:

Sartorius Stedim Biotech



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.